Download PDF
1 / Pages

Other users also viewed these articles

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R. Bernal-Reyes; M.E. Icaza-Chávez; L.A. Chi-Cervera; J.M. Remes-Troche; M. Amieva-Balmori; B.A. Priego-Parra; S. Martínez-Vázquez; I.O. Méndez-Guerrero; L. Martínez-Rodríguez; A. Barranca-Enríquez; C. Palmeros-Exsome; A.D. Cano-Contreras; A. Triana-Romero;
Rev Gastroenterol Mex. 2023;88:199-207
Cancer of the digestive system in Veracruz. The magnitude of the problem by 2025 F. Roesch-Dietlen; K.J. Ortuño-García; M. González-Santés; P. Grube-Pagola; J.M. Remes-Troche; F. Díaz-Roesch; A.D. Cano-Contreras; C.S. Silva-Cañetas;
Rev Gastroenterol Mex. 2020;85:145-50
Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD B.A. Priego-Parra; A. Triana-Romero; R. Bernal-Reyes; M.E. Icaza-Chávez; S.E. Martínez-Vázquez; M. Amieva-Balmori; A.D. Cano-Contreras; H. Vivanco-Cid; J.M. Remes-Troche;
Rev Gastroenterol Mex. 2024;89:498-505